Genocea Biosciences, Inc.

DB:GBI1 Stock Report

Market Cap: €655.7k

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Genocea Biosciences Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of GBI1?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders49,8410.0848%
Institutions2,035,4823.46%
Public Companies4,626,3897.87%
Hedge Funds5,084,1848.65%
General Public46,987,60779.9%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 3.1%.


Top Shareholders

Top 16 shareholders own 20.07% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
8.65%
Avoro Capital Advisors LLC
5,084,184€56.7k0%no data
7.87%
GSK plc
4,626,389€51.6k0%no data
2.68%
The Vanguard Group, Inc.
1,574,979€17.6k0%no data
0.64%
Ally Bridge Group
375,000€4.2k0%no data
0.13%
Abaris Investment Management AG
75,000€836.70%no data
0.048%
William Clark
28,205€314.6-74%no data
0.017%
Empirical Asset Management, Llc
10,000€111.50%no data
0.015%
Girish Aakalu
8,655€96.532.3%no data
0.0094%
Jacquelyn Sumer
5,500€61.4-31.3%no data
0.0066%
Katrine Bosley
3,887€43.30%no data
0.0043%
Thomas Davis
2,526€28.2-69.8%no data
0.00087%
Jessica Flechtner
514€5.7-96.3%no data
0.00085%
Simplex Trading, LLC, Asset Management Arm
500€5.6-94.4%no data
0.00051%
Diantha Duvall
302€3.3-97.7%no data
0.00043%
George Siber
252€2.8-98.8%no data
0.00001%
Barclays PLC Private Banking & Investment Banking Investment
3€0.070%no data